Source: Virtual Congress 2020 – Biological mechanisms of lung cancer
Disease area: Thoracic oncology



Rating:

Share or cite this content

Citations should be made in the following way:
G. Giotopoulou (Munich, Germany), M. Pepe (Munich, Germany), S. Behrend (Munich, Germany), G. Ntaliarda (Patras, Greece), A. Lamort (Munich, Germany), I. Lillis (Patras, Greece), M. Spella (Patras, Greece), G. Stathopoulos (Munich, Germany). Causal RNA signatures in lung adenocarcinoma. 1759

Member's Comments

No comment yet.

Related content which might interest you: Mutational RNA signatures in environmentally-induced lung adenocarcinoma Source: Virtual Congress 2021 – Novel insights into the pathogenesis of chronic lung diseases Year: 2021 PP135 – Mutational RNA signatures in environmentally-induced lung adenocarcinoma Source: ERS Lung Science Conference 2021 Year: 2021 Mouse lung adenocarcinoma cell lines as tools to identify novel lung cancer genes Source: ERS Lung Science Conference 2017 Year: 2017 Evolution of microRNA expression during human bronchial squamous carcinogenesis Source: Eur Respir J 2009; 33: 352-359 Year: 2009 MicroRNA clusters: dysregulation in lung adenocarcinoma and COPD Source: Eur Respir J 2014; 43: 1740-1749 Year: 2014 Molecular signatures of non-small cell lung cancer (NSCLC) obtained from gene expression profiling of the benign bronchial mucosa of smokers with and without NSCLC Source: Annual Congress 2013 –Biology and molecular pathology of lung cancer Year: 2013 Analysis of circular RNAs expression profile in pleural metastases from lung adenocarcinoma Source: Virtual Congress 2020 – Novel directions in pleural disease: bench to bedside Year: 2020 Gene expression profile in lung adenocarcinoma and non-cancerous lung tissue Source: Eur Respir J 2005; 26: Suppl. 49, 456s Year: 2005 LSC - 2021 - Mutational RNA signatures in environmentally-induced lung adenocarcinoma Source: Virtual Congress 2021 – New clinical and biological developments in lung cancer Year: 2021 Fusion transcripts in lung cancer Source: International Congress 2017 – Lung cancer: latest basic research on molecular alterations, tumour-immune system-microenvironment interplay and the metabolome Year: 2017 Molecular biomarkers for lung adenocarcinoma Source: Eur Respir J , 49 (4)  1601734; DOI: 10.1183/13993003.01734-2016 Year: 2017 Differential expression analysis of lncRNA in different types of lung cancer Source: Virtual Congress 2021 – Novel insights into the pathogenesis of chronic lung diseases Year: 2021 Gene expression profiling reveal novel biomarkers in non-small cell lung cancer Source: Annual Congress 2010 - Recent developments of molecular pathology and functional genomics in non-neoplastic and neoplastic lung diseases Year: 2010 Identifying a tissue specific microRNA molecular signature in lung cancer Source: Virtual Congress 2021 – Biology of lung cancer: preclinical and translational research Year: 2021 Hypermethylation pattern in genomic DNA samples derived from tumor and serum of resected non-small cell lung cancer patients Source: Eur Respir J 2004; 24: Suppl. 48, 674s Year: 2004 LSC Abstract – Transcriptomic profiling of macrophages isolated from human non-small cell lung carcinoma (NSCLC) reveals novel macrophage subsets with distinct tumour response features Source: International Congress 2016 – Lung cancer immunology: latest research Year: 2016 Expression profiling in hypoxic non-small cell lung cancer explants reveals a four-gene hypoxia signature Source: Annual Congress 2011 - Lung cancer: molecular pathology and functional genomics Year: 2011 Multiple carcinomas in the lung cancer patients Source: Eur Respir J 2007; 30: Suppl. 51, 671s Year: 2007 Prognostic value of microRNAs profiling in early stage squamous cell lung cancer Source: Annual Congress 2009 - Hot topics in molecular pathology and functional genomics of lung cancer Year: 2009